tirzepatide reaction at injection site : r/tirzepatidecompound Tirzepatide-Induced Injection Site Reaction |
Description
Wegovy is given by subcutaneous injection once a week at a dose of 2.4 mg
Altissimi G, Salviati M, Turchetta R, et al
Additional information Enhanced Digital Features To view enhanced digital features for this article go to Electronic supplementary material Below is the link to the electronic supplementary material
Beyond a point, cells become desensitised to the insulin, a scenario known as insulin resistance
Your healthcare provider may adjust your schedule based on your individual health needs, tolerability, and progress
Discontinuation rates in Phase 3 were 12.2% at the 9mg dose and 18.2% at 12mg, compared to 4% on placebo
